- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Beta Drugs Limited — Updates, 11-01-2026: General Updates
11-01-2026 | 10:20 am
11-01-2026 | 10:20 am
Beta Drugs acquired a 66.09% stake in Nivian Lifesciences for ₹69.4 Cr, valuing Nivian at ₹105 Cr. Nivian, an IVF therapy specialist, eyes ₹43 Cr sales in FY26. This move strengthens Beta's position in the high-growth women's health and fertility market.
No comments yet. Be the first to comment!